Not exact matches
Previous genetic studies have examined the association of aspirin, NSAIDs, or both with colorectal cancer according to a limited number of candidate genes or pathways.6 - 10 Thus, to comprehensively identify common genetic markers that characterize individuals who may
obtain differential benefit from aspirin and NSAIDs, we conducted a discovery - based, genome - wide analysis of gene × environment interactions between regular use of aspirin, NSAIDs, or both and single -
nucleotide polymorphisms (SNPs) in relation to risk of colorectal cancer.
Here we report a public database of common variation in the human genome: more than one million single
nucleotide polymorphisms (SNPs) for which accurate and complete genotypes have been
obtained in 269 DNA samples from four populations, including ten 500 - kilobase regions in which essentially all information about common DNA variation has been extracted.
In a new study, Sklar and her colleagues are scanning 500,000 gene variants, known as single
nucleotide polymorphisms,
obtained from a sampling of patients with bipolar disorder.
Microsatellite genotypes were
obtained for 203 clinical infection samples from eight locations, and Illumina paired - end sequences were
obtained to yield high coverage genome - wide single
nucleotide polymorphism (SNP) data for 65 clinical infection samples from four locations.